These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25751094)

  • 1. Asymmetric biodegradable microdevices for cell-borne drug delivery.
    Xia J; Wang Z; Huang D; Yan Y; Li Y; Guan J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6293-9. PubMed ID: 25751094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.
    Grayson AC; Cima MJ; Langer R
    Biomaterials; 2005 May; 26(14):2137-45. PubMed ID: 15576189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
    Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
    Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
    Clark A; Milbrandt TA; Hilt JZ; Puleo DA
    Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.
    Fredenberg S; Wahlgren M; Reslow M; Axelsson A
    Int J Pharm; 2011 Aug; 415(1-2):34-52. PubMed ID: 21640806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells.
    Newman KD; McBurney MW
    Biomaterials; 2004 Nov; 25(26):5763-71. PubMed ID: 15147822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
    Shi X; Wang Y; Ren L; Huang W; Wang DA
    Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porous PLGA scaffolds for controlled release of naked and polyethyleneimine-complexed DNA.
    Ravi N; Gupta G; Milbrandt TA; Puleo DA
    Biomed Mater; 2012 Oct; 7(5):055007. PubMed ID: 22909549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
    Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
    Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.
    Fahmy TM; Samstein RM; Harness CC; Mark Saltzman W
    Biomaterials; 2005 Oct; 26(28):5727-36. PubMed ID: 15878378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
    Yoon JJ; Chung HJ; Lee HJ; Park TG
    J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering.
    Ji Y; Xu GP; Zhang ZP; Xia JJ; Yan JL; Pan SH
    Ann Biomed Eng; 2010 Mar; 38(3):632-9. PubMed ID: 20049636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ nanomechanical characterization of the early stages of swelling and degradation of a biodegradable polymer.
    Dumitru AC; Espinosa FM; Garcia R; Foschi G; Tortorella S; Valle F; Dallavalle M; Zerbetto F; Biscarini F
    Nanoscale; 2015 Mar; 7(12):5403-10. PubMed ID: 25727249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antiproliferative drug coating for glaucoma drainage devices.
    Ponnusamy T; Yu H; John VT; Ayyala RS; Blake DA
    J Glaucoma; 2014; 23(8):526-34. PubMed ID: 23632409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.